| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.49 | 4e-15 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-07 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.34 | 6e-06 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.31 | 9e-06 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0004 |